These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12533672)

  • 1. Clinically potential subclasses of retinoid synergists revealed by gene expression profiling.
    Ishida S; Shigemoto-Mogami Y; Kagechika H; Shudo K; Ozawa S; Sawada J; Ohno Y; Inoue K
    Mol Cancer Ther; 2003 Jan; 2(1):49-58. PubMed ID: 12533672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel synthetic retinoids and separation of the pleiotropic retinoidal activities.
    Kagechika H
    Curr Med Chem; 2002 Mar; 9(5):591-608. PubMed ID: 11945126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin proteolysis as a retinoid cancer prevention mechanism.
    Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
    Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: possibly the true retinoid receptor.
    Hashimoto Y; Kagechika H; Kawachi E; Shudo K
    Jpn J Cancer Res; 1988 Apr; 79(4):473-83. PubMed ID: 2838445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis.
    Ishida S; Shigemoto-Mogami Y; Shinozaki Y; Kagechika H; Shudo K; Ozawa S; Sawada J; Ohno Y; Inoue K
    Biochem Pharmacol; 2004 Dec; 68(11):2177-86. PubMed ID: 15498508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent retinoid synergists with a diphenylamine skeleton.
    Ohta K; Tsuji M; Kawachi E; Fukasawa H; Hashimoto Y; Shudo K; Kagechika H
    Biol Pharm Bull; 1998 May; 21(5):544-6. PubMed ID: 9635518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.
    Umemiya H; Fukasawa H; Ebisawa M; Eyrolles L; Kawachi E; Eisenmann G; Gronemeyer H; Hashimoto Y; Shudo K; Kagechika H
    J Med Chem; 1997 Dec; 40(26):4222-34. PubMed ID: 9435893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How retinoids regulate breast cancer cell proliferation and apoptosis.
    Simeone AM; Tari AM
    Cell Mol Life Sci; 2004 Jun; 61(12):1475-84. PubMed ID: 15197471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
    Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
    Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergists for retinoid in cellular differentiation of human promyelocytic leukemia cells HL-60.
    Umemiya H; Kawachi E; Kagechika H; Fukasawa H; Hashimoto Y; Shudo K
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1827-9. PubMed ID: 8536354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in retinoids studies].
    Kagechika H; Hashimoto Y; Kawachi E; Shudo K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2839-47. PubMed ID: 3052300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin.
    Oya Y; Mondal A; Rawangkan A; Umsumarng S; Iida K; Watanabe T; Kanno M; Suzuki K; Li Z; Kagechika H; Shudo K; Fujiki H; Suganuma M
    J Nutr Biochem; 2017 Apr; 42():7-16. PubMed ID: 28103535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3.
    Takahashi H; Hatta Y; Iriyama N; Hasegawa Y; Uchida H; Nakagawa M; Makishima M; Takeuchi J; Takei M
    PLoS One; 2014; 9(11):e113722. PubMed ID: 25409436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyenylidene thiazolidinedione derivatives with retinoidal activities.
    Tashima T; Kagechika H; Tsuji M; Fukasawa H; Kawachi E; Hashimoto Y; Shudo K
    Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1805-13. PubMed ID: 9396157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression analysis of human promyelocytic leukemia HL-60 cell differentiation and cytotoxicity induced by natural and synthetic retinoids.
    Wang J; Fong CC; Tzang CH; Xiao P; Han R; Yang M
    Life Sci; 2009 Apr; 84(17-18):576-83. PubMed ID: 26324987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
    Kim HT; Kong G; Denardo D; Li Y; Uray I; Pal S; Mohsin S; Hilsenbeck SG; Bissonnette R; Lamph WW; Johnson K; Brown PH
    Cancer Res; 2006 Dec; 66(24):12009-18. PubMed ID: 17178900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta.
    Uruno A; Noguchi N; Matsuda K; Nata K; Yoshikawa T; Chikamatsu Y; Kagechika H; Harigae H; Ito S; Okamoto H; Sugawara A
    J Leukoc Biol; 2011 Aug; 90(2):235-47. PubMed ID: 21393419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
    Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid.
    Sanda T; Iida S; Kayukawa S; Ueda R
    Haematologica; 2007 Jan; 92(1):115-20. PubMed ID: 17229644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.